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THROUGH 
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!.Quantify the pulsatile flow field for post-prandial and exercise conditions in a 
model of the human abdominal aorta using magnetic resonance imaging, 
2. Verify selected velocity measurements using MRI in a human aorta, 
3. Correlate the hemodynamic parameters with raised plaque and intimal thickness 
obtained from pathology specimens. 
Methods. In general, the methods for achieving the goals have been refined from 
the original grant proposal. Magnetic resonance velocimetry is now the preferred 
technique for measuring the complex three-dimensional velocities in the models. This 
technique can also be used to verify the hemodynamic assumptions through direct in vivo 
measurement. A new method has been developed to estimate the time varying wall shear 
stress in any artery. The time-varying wall shear stress can be approximated using an 
analytical solution for unsteady flow through straight tubes developed by Hale, 
McDonald and Wormersley. Through the use of recent mathematical software, this 
solution is easy to produce on a personal computer and a program has been developed to 
calculate the time-varying wall shear stress from the pulsatile flow rate in a vessel. 
Details of this computer solution are given in an attached manuscript. New computer 
graphics capabilities have been added to speed the analysis and correlation between the 
many hemodynamic and morphologic variables. Otherwise, the experimental design 
remains basically the same and the original objectives should be achieved. 
2. RESULTS 
The objective of this year's studies was to make quantitative measurements of 
velocity and wall shear stress for rest conditions in the model of the human abdominal 
aorta. Additionally, a new technique has been developed to calculate the unsteady shear 
stress at the wall from the centerline velocity or the total flow rate. Since the centerline 
velocity or flow waveform can be obtained by a number of non-invasive means (eg. 
ultrasound, plethysmography, MRI, a better estimate of oscillatory wall shear stress can 
now be made on an individual basis. 
The Abdominal Aorta 
As specified in the grant, the hemodynamic flow field in this complex part of the 
vasculature was quantified using a glass blown model of the aorta. To simulate exercise, 
the distal resistance to the legs was greatly reduced, and the cardiac output was doubled 
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of the sixteen time points throughout the cardiac cycle. Six shear stress measures were 
evaluated from the shear stress profiles. The mean shear stress was evaluated by taking 
the time average of the pulsatile shear stress values at each location around the 
circumference of the vessel. The maximum and minimum shear stress values were 
selected and subtracted to give the pulse shear stress. The percent of the cardiac cycle 
when the shear stress was negative (NEG) was evaluated, and an oscillatory shear index 
(OSI), which represents the amount of negative shear as a fraction of the total shear stress 
magnitude, was computed for the axially directed shear stress, with values ranging from 0 
to 1. 
Velocity profiles were taken at several locations along the aortic model. For the 
suprarenal aorta under normal resting conditions the shear stress changed during the 
cardiac cycle as shown in Figure 1a. The avera~e mean shear stress values measured 
around the circumference was 1.3 dynes/em , with a standard deviation of 0.6 
dynes/cm2. The spatial maximum, minimum and pulse shear stresses were 8.4, -4.1, and 
12.5 dynes/cm2 over the cardiac cycle. 
In the infrarenal abdominal aorta, resting mean shear stress strongly oscillated along 
the posterior wall for much of the cycle shown in Figure 1 b. At the posterior wall, the 
length of the reverse flow resulted in a time-averaged mean shear stress of -5.0 
dynes/cm2. The shear stress was negative for 75% of the cardiac cycle (NEG) and the 
OSI was 0.9. Elsewhere in the abdominal aorta, the mean shear stress was positive. The 
most negative shear stress value in the infrarenal aorta was -12.0 dynes/cm2 at the 
posterior wall of the abdominal aorta and along the lateral posterior walls of the aortic 
bifurcation. 
Shear stress measurements under simulated exercise conditions revealed that shear 
stress reversal was generally abolished throughout the abdominal aorta as depicted in 
Figure 2. The mean shear stresses were all positive at this location, ranging from 5.4 
dynes/cm2 at the posterior wall to 10.6 dynes/cm2 at the left lateral wall. Only a very 
small area at the posterial experienced a short duration negative shear stress ( -1.81 
dynes/cm2) at the posterior wall. The shear stress was negative for a maximum of 18% 
of the cardiac cycle in this region while OSI was 0.03 at the same location. Elsewhere in 
the aorta, NEG and OSI were zero. 
Thus, the hemodynamic shear stress environment in the suprarenal aorta is 
fundamentally different from the infrarenal abdominal aorta and aortic bifurcation under 
resting conditions. For simulated exercise conditions, the overall mean shear stress 
becomes greater, and flow becomes much more linear with an elimination of most of the 
reversal of direction in wall shear stress. 
The Superficial Femoral and Coronary Arteries 
Atherosclerosis develops at two other important clinical sites: the superficial 
femoral artery (SFA) and the coronary arteries. Disease in the SFA is actually broad 
based and extends throughout this segment. Focal atherosclerosis in the coronary 
arteries represent the greatest cause of morbidity in the industrialized world. 
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The hemodynamics in the SFA is dominated by the pulsatile character of the flow 
waveform more than the simple geometry of this relatively straight vessel. The balance 
of the renal versus leg peripheral resistance creates a triphasic flow waveform pattern 
throughout the SFA by the same mechanism as in the abdominal aorta. For the 
superficial femoral artery, a pulsatile wall shear stress can be calculated from the flow 
waveform given in Figure 3. The mean shear stress through this artery was 5 dynes/cm2 
and the minimum shear stress was -20 dynes/cm2. However, it is obvious that the shear 
stress oscillates around zero causing the shear forces to reverse direction through the 
cardiac cycle. The OSI for this arterial segment was 0.35 and NEG was 30%. 
Hemodynamically, the coronary artery system is very difficult to simulate in vitro, 
being a branch flow on a moving surface. However, as a frrst approximation, one can use 
the calculated Wormersley solution to derive the unsteady wall shear stress for the 
coronary flow waveform. Flow through the left anterior descending (LAD) coronary 
artery is primarily diastolic. During systole, flow can actually reverse as blood is 
squeezed backwards from the myocardium. The coronary arteries can experience an 
oscillatory shear stress as illustrated in Figure 4. The mean shear stress was 10 
dynes/cm2, the minimum shear stress was -8 dynes/cm2, the OSI was 0.06 and NEG was 
7o/o. The hemodynamic wall shear stress in the LAD oscillates in direction and has a large 
negative shear stress at this site of important clinical disease. 
Significance to atherogenesis. Locations of aortic atherosclerosis show a strong 
qualitative relation to the areas of oscillatory shear stress and low mean shear stress. 
therosclerosis in the abdominal aorta is generally confined to the infrarenal segment. 
e NHLBI sponsored Pathological Determinents of Atherosclerosis in Youth (PDA Y) 
study of over 300 aortas has provided detailed probability of occurrence maps for raised 
plaque. The distribution of these plaques clearly indicates that the posterior section of the 
aorta and the lateral posterior portion of the aortic bifurcation are most diseased. Thus, in 
the abdominal aorta, locations of raised plaque appear to coincide well with the locations 
of low shear stress and areas of oscillating shear direction. 
Other locations of atherosclerotic plaque such as the superficial femoral artery and 
the coronary arteries appear to be a specific site of significant oscillations in shear stress 
with transient negative shear stress less than -5 dynes/cm2. Atherosclerotic plaque in the 
coronary generally consists of segmental disease which is more prevalent at the outer 
walls of the branch. In contrast, arteries typically free of disease are expected to 
experience biphasic flow with predominantly unidirectional shear stresses. 
Hemodynamic forces likely play a critical role in the development of 
atherosclerosis. The detailed, physiologic, time-varying magnitudes and directions of 
these shear forces must be defined if we are to fully understand this complex disease. 
Future statistical correlations should help define the exact hemodynamic pattern 
responsible for atherognetic transformation. 
These pulsatile shear conditions will have important ramifications on the evaluation 
of endothelial response to physiologic shear flows. Only through the quantification of 
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physiologic pulsatile arterial hemodynamics can one properly define the appropriate 
hemodynamic environment in which to study the biology of vascular cells. Without this 
information, irrelevant studies may be performed on the effects of non-physiologic 
mechanical stress on the vascular cells. The shear waveforms presented here will aid in 
the development of accurate hemodynamic environments for future cellular 
investigations. 
3. The protocols for human subjects have not changed. 
4. No vertebrate animal studies are involved. 
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Figure 1 
Shear stress waveforms for the suprarenal (a) and infrarenal (b) abdominal 
aorta. In the suprarenal aona, the shear stress transiently reverses with a 
minimum value of only -2 dynes/cin2. In contrast, the shear stress in the 
diseased infrarenal aorta, oscillates two times during the cycle with a 
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Figure 2 
Shear stress versus time for exercise in the infrarenal abdominal aorta 
indicating the laminarization of flow and diminishing oscillatory nature of 
the waveform. The minimum value of shear under exercise conditions is 













(a) centerline velocity (cm/s) 







(a) Flow rate (ml/s) 
(b) Wall shear stress (dyn/cm2 ) 
Figure 3 Figure 4 
Flow and shear stress waveforms for the superficial femoral artery 
estimated from the analyti~ solution of unsteady flow through a straight 
tube. The waveform oscillates around zero two times for the cardiac cycle 
with a minimum value of -20dynes/cm2 for the SFA. 
Flow and shear stress waveforms for the left anterior descending coronary 
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navenorfesolved the disallowance. (Definition exckJdes disallowances in an "appeal" status.) 
Where the applicant discloses delinquency on debt to the Federal Government, the PHS shall (1) take such infonnation into account when 
determining whether the prospective grantee organization is responsible with respect to that grant, and (2) consider not making the grant 
until payment is made or satisfactory arrangements are made With the agency to whom the debt is owed. Therefore, it may be necessary 
for the PHS to contact the applicant before a grant can be made to confinn the status of the debt and ascertain the payment arrangements 
for its liquidation. Applicants that fail to liquidate indebtedness to the Federal Government in a businesslike manner place themselves at 
risk of not receiving financial assistance from the PHS. 
b. Debannent and SUspension. ~ No 0 Yes (If "Yes," attach explanation.) 
Before a grant award can be made, the applicant organization must certify, among other things, that neither it nor its principals are presently 
debarred, suspended, proposed for debannent, declared ineligible, or voluntarily excluded from covered transactions by any Federal 
department or agency. Subawardees, that is, other corporations, partnerships, or other legal entities (called "lower tier" participants), must 
make the same certification to the applicant organization concerning their covered transactions. Please refer to the pertinent DHHS 
implementing regulations, Title 45 Code of Federal Regulations Part 76, for complete certification requirements. 
c. Drug-free Wori<place. I8J Yes D No (If "No," attach explanation.) 
Before a grant award can be made, the applicant organization must certify that it will provide a drug-free workplace. The main points of the 
certification require the applicant organization to: 
• Publish a statement notifying employees that the unlawful manufacture, distribution, dispensation, possession, or use of a controlled 
substance is prohmned in the workplace and specifying the actions that will be taken against employees for violation of such prohibition; 
• Establish a drug-lree awareness program: 
• Require that each employee engaged in the perfonnance of a grant or contract be provided a copy of the published statement; 
• Notify the employee that as a condition of employment, the employee will abide by the tenns of the statement: 
• Notify the PHS awarding component of any employee convicted of a drug violation occurring in the workplace: and 
• Require any employee who is convicted of a drug offense occurring in the workplace to participate in a rehabilitation program. 
Please refer to the pertinent DHHS implementing regulations, Title 45 Code of Federal Regulations Part 76, for complete certification 
requirements. 
NliECT COST CALCUlATION 
Indicate the applicant organization's most recent indirect cost rate established with the appropriate DHHS Regional Office, or, in the case of 
for-profrt organizations, the rate established with the appropriate PHS Agency Cost Advisory Office. Indirect costs will not be paid on foreign 
grants, construction grants, grants to Federal organizations and grants to individuals, and usually not on conference grants. Follow any 
additional instructions provided for Research Career Development Awards, Institutional National Research Service Awards, and specialized 
grant appUcations. 
0 DHHS Agreement Dated:--------- 0 No Indirect Costs Requested 
0 No DHHS Agreement, but rates established with _O;.....;N_R"'-------------
*CALCULATlON 
Enter proposed budget period: 
DATE 6/1/90 
Amount of Base$ 66,688 x Rate Applied 62.5% % Indirect Costs $...;;4L.ol1...,.~6.u8.u0"------
Add to total direct costs from page 2 and enter new total on FACE PAGE, Item 1 Ob 
*Check appropriate box(es) 
D Salary and wage base 0 Modified total direct costs base D Other base (Attach explanation) 
0 Off-site, other special rate, or more than one rate involved (Attach explanation) 
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